Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tudor Paul Tamaș und 1 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Immunology and Allergology, Biology, Department of Functional Sciences III, "Victor Babeș" University of Medicine and Pharmacy, Eftimie…. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Hypersensitivity, Allergens. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy Timisoara.
Abstract (Originalsprache)
Allergen immunotherapy (AIT) is a well-established treatment aimed at reducing allergen sensitivity by gradually exposing the immune system to increasing doses of allergens. This promotes desensitization and immune tolerance through multiple mechanisms. AIT offers long-term immune modulation and is considered a potentially curative certain forms of allergic diseases. Altered antibody responses is a key mechanism of AIT in the production of allergen-specific IgG4 antibodies, which act as blocking antibodies to prevent allergen binding to IgE on mast cells (MCs) and basophils. However, IgG4 responses are sometimes ineffective due to variations in antibody affinity and epitope targeting. Reverse class switching from IgE to IgG4 and selective depletion of IgE-producing B cells represent potential strategies to improve AIT efficacy. Tregs play a central role in AIT by suppressing Th2-driven allergic responses and promoting immune tolerance through anti-inflammatory cytokines interleukin (IL)-10 and transforming growth factor (TGF)-β. However, genetic and environmental factors may impair Treg function, leading to AIT failure. AIT reduces MC and basophil activation, leading to long-term suppression of allergic inflammation. It modulates IgE-FcεRI interactions and cytokine signaling pathways, but in some cases, anaphylactic reactions or resistance to MC desensitization may occur. Discussion and conclusions: While AIT is a highly effective allergy treatment, variability in immune responses can impact its success. Advances in biologic therapies offer potential synergies with AIT. Understanding these interactions will help refine AIT strategies and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Immunology and Allergology, Biology, Department of Functional Sciences III, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timişoara, Romania.
- Discipline of Physiology, Department of Functional Sciences III, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timişoara, Romania.
- Center of Immuno-Physiology and Biotechnologies (CIFBIOTEH), "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timişoara, Romania.
ORCID-Profile: Tudor Paul Tamaș, Elena Ciurariu
Förderung
- Victor Babes University of Medicine and Pharmacy Timisoara
Zitieren
APA
Tamaș, T. P., & Ciurariu, E. (2025). Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083535
Vancouver
Tamaș TP, Ciurariu E. Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083535
BibTeX
@article{Tama2025,
author = {Tamaș, Tudor Paul and Ciurariu, Elena},
title = {Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083535}
}
EUVIMED